Abstract

The designs of potent neuraminidase (NA) inhibitors are an efficient way to deal with the recent “2009 H1N1” influenza epidemic. In this work, density functional calculations were employed to study the conformation, stability and formation of the zwitterions of 5-[(1R,2S)-1-(acetylamino)-2-methoxy-2-methylpentyl]-4-[(1Z)-1-propenyl]-(4S,5R)-d-proline (BL), a proline-based NA inhibitor. Compared to proline, the zwitterion stability of BL is enhanced by 1.76 kcal mol−1 due to the introduction of functional groups. However, the zwitterion of BL will not represent a local minimum on the potential energy surface until the number of water molecules increases up to two (n = 2). With the addition of two and three water molecules, the energy differences between the zwitterions and corresponding canonical isomers were calculated at 3.13 and −1.54 kcal mol−1, respectively. The zwitterions of BL are mainly stabilized by the H-bonds with the water molecules, especially in the case of three water molecules where the carboxyl-O atoms are largely coordination-saturated by three H-bonds of medium strengths, causing the zwitterion stability even superior to the canonical isomer. With the presence of two and three water molecules, the energy barriers for the conversion processes from the canonical isomers to the zwitterions are equal to 4.96 and 3.13 kcal mol−1, respectively. It indicated that the zwitterion formation is facile to take place with addition of two molecules and further facilitated by more water molecules. Besides, the zwitterion formation of BL is finished in a single step, different from other NA inhibitors. Owing to the above advantages, BL is a good NA inhibitor candidate and more attention should be paid to explorations of BL-based drugs.

Highlights

  • Influenza A (H1N1) is a subtype of influenza virus A and the most common cause of influenza in humans

  • 4.96 and 3.13 kcal mol-1, respectively. It indicated that the zwitterion formation is facile to take place with addition of two molecules and further facilitated by more water molecules

  • WHO was just informed that the H1N1 viruses are resistant to the most widely used antiviral drug—oseltamivir [7,8]

Read more

Summary

Introduction

Influenza A (H1N1) is a subtype of influenza virus A and the most common cause of influenza in humans. There are only restricted antiviral agents that can be considered to prevent and treat the influenza [3,4,5,6]. WHO was just informed that the H1N1 viruses are resistant to the most widely used antiviral drug—oseltamivir (known as Tamiflu®) [7,8]. The development of new generation anti-influenza drugs is of special urgency and significance [3,4,5,6]. 5-[(1R,2S)1-(acetylamino)-2-methoxy-2-methylpentyl]-4-[(1Z)-1-propenyl)-(4S,5R)]-D-proline (Scheme 1) has been successfully designed and shown potential application as an anti-influenza drug [16,17,18]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call